The highlights of 2017 FINA World ChampionshipsSport July 25, 19:37
IAAF to hear report on Russia’s reinstatement ahead of 2017 Athletics World ChampionshipSport July 25, 19:25
EU Council to discuss Nord Stream 2 project in SeptemberBusiness & Economy July 25, 19:13
Berlin preparing common European response to Siemens turbines supplies to Crimea — sourceBusiness & Economy July 25, 18:49
Finnish president: Dialog with Putin is direct and clearWorld July 25, 18:22
Summer surprises: Arctic swelters in heatwave, while resorts soak in rainBusiness & Economy July 25, 18:03
Sports minister says RUSADA doping inspectors started testing athletesSport July 25, 17:25
Arctic shelf development tops agenda of Murmansk international business weekBusiness & Economy July 25, 17:08
Trump backs investigation into Kiev’s meddling attempts to sabotage his election campaignWorld July 25, 16:57
BASEL, January 29. /ITAR-TASS/. Russia ranks second by the pharmaceutical market of over-the-counter medications, goes a report of the multinational pharmaceutical corporation Novartis.
According to the statements, the country became the world's second largest market and the strongest driver in this segment with its “double-digit growth” of over-the-counter drug sales.
As for the brands popular in Russia, Novartis cites anti-inflammatory drug Voltaren, nasal spray Otrivin and cold symptom-fighting powder Theraflu. Growth in sales of the two latter drugs increased due to cold winter, Novartis explains.
2013 financial statements came out on Wednesday showing Novartis’ revenue 2.2% up to 57.92 billion. Net profit declined 1% to 9.3 billion.
The company does not disclose over-the-counter sales summing the figure up with revenue from veterinary drugs. Sales in the segment grew 8.8% to 4.06 billion in 2013.
Novartis International AG set up in 1996 is Europe’s second pharmaceutical producer by market share with 120,000 employees operating in 140 countries. In Russia, Novartis has three kinds of businesses: over-the-counter medications, contact lenses and veterinary drugs.